Opdivo (nivolumab) was turned down as a treatment for advanced bladder cancer, after being reviewed through the SMC’s Patient and Clinician Engagement (PACE) process, which looks at end of life medicines or those for very […]
The first human trial of a drug for Huntington’s disease has shown it to be safe, well-tolerated and successful in lowering the level of huntingtin protein in the nervous system. The phase I/IIa trial comprised […]
The economic cost of asthma in the United States is nearly $82 billion a year, federal health officials report. That figure includes medical expenses and costs associated with work and school absences and deaths. However, […]
The long latency period between human papillomavirus (HPV) exposure and the emergence of cervical and genital pre-cancers/cancers means that there is a need for long-term follow-up of vaccinated pre-adolescents and adolescents. In a study in […]
The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation. These mutated genes, called BRCA1 and BRCA2, first came to prominence […]